Skip to main content

HSBC HOLDINGS PLC

Position in CRL — Charles River Laboratories International, Inc.

CIK 873630 LONDON, X0

Position in CRL

as of Mar 31, 2026 · filed Apr 30, 2026
Position Value
$12,020,143
-$364,370 QoQ
Shares Held
69,682
+12.2% QoQ
Ownership
0.145%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in CRL Over Time

Shares Held

Position Value (USD)

Derivatives in CRL

reported options exposure · as of Sep 30, 2021
CallValue
$0
CallShares
0
PutValue
$660,272
PutShares
1,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

HSBC HOLDINGS PLC holds $1,313,838,116 across 21 Diagnostics & Research names. CRL ranks #14 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CRL

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $12,020,143 69,682
2025-12-31 $12,384,513 62,084
2025-09-30 $12,979,919 82,960
2025-06-30 $11,605,218 76,486
2025-03-31 $12,314,491 81,813
2024-12-31 $14,805,287 80,202
2024-09-30 $16,130,659 81,894
2024-06-30 $20,342,963 98,475
2024-03-31 $20,931,969 77,254
2023-12-31 $13,256,129 56,075
2023-09-30 $12,374,765 63,143
2023-06-30 $11,362,119 54,041
2023-03-31 $8,724,273 43,228
2022-12-31 $11,400,744 52,321
2022-09-30 $7,196,188 36,566
2022-06-30 $7,778,450 36,353
2022-03-31 $12,899,337 45,425
2021-12-31 $16,564,001 43,962
2021-09-30 $660,272 1,600
2021-09-30 $16,236,499 39,345
2021-06-30 $11,756,797 31,782
2021-06-30 $591,872 1,600
2021-03-31 $1,787,381 6,167
2020-12-31 $1,888,691 7,559
2020-09-30 $622,284 2,748
2020-06-30 $277,739 1,593
2020-03-31 $251,157 1,990